Southport Capital Management’s Celgene Corp CELG Stock Holding History

Southport Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-34	Closed	-$3K	–	599
2018 Q3	$3K	Buy	+34	New	+$3K	﹤0.01%	544
2015 Q3	–	Sell	-3,265	Closed	-$378K	–	176
2015 Q2	$378K	Buy	3,265 +265	+9%	+$30.3K	0.23%	110
2015 Q1	$346K	Sell	3,000 -1,100	-27%	-$131K	0.2%	110
2014 Q4	$459K	Buy	+4,100	New	+$432K	0.27%	93

Other funds holding CELG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Southport Capital Management's CELG Position: Q4 2018 in Review

Southport Capital Management sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 34 shares — an estimated $3K sold.

Southport Capital Management first reported a position in CELG in Q4 2014 and held it in 4 quarters. The position peaked at $459K in Q4 2014. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

Southport Capital Management reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
Southport Capital Management sold 34 Celgene Corp shares in Q4 2018, an estimated $3K.
Southport Capital Management first reported a position in Celgene Corp in Q4 2014 and held it in 4 quarters.
Southport Capital Management's Celgene Corp position peaked at $459K in Q4 2014.
1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Southport Capital Management's 13F filing for Q4 2018, filed 18 Jan 2019.